Changjiang Qin

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 01, 2022
PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells.

Changjiang Qin, Zhiyu Ji, Ertao Zhai

Pageof 1

Frequent Collaborators

1 joint publications

Zhiyu Ji